33 related articles for article (PubMed ID: 18357800)
1. Factors influencing the cognitive and neural effects of hormone treatment during aging in a rodent model.
Chisholm NC; Juraska JM
Brain Res; 2013 Jun; 1514():40-9. PubMed ID: 23419893
[TBL] [Abstract][Full Text] [Related]
2. A component of Premarin(®) enhances multiple cognitive functions and influences nicotinic receptor expression.
Talboom JS; Engler-Chiurazzi EB; Whiteaker P; Simard AR; Lukas R; Acosta JI; Prokai L; Bimonte-Nelson HA
Horm Behav; 2010 Nov; 58(5):917-28. PubMed ID: 20849857
[TBL] [Abstract][Full Text] [Related]
3. The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women.
Edlefsen KL; Jackson RD; Prentice RL; Janssen I; Rajkovic A; O'Sullivan MJ; Anderson G
Menopause; 2010; 17(3):622-9. PubMed ID: 20215977
[TBL] [Abstract][Full Text] [Related]
4. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of single- and multiple-dose pharmacokinetics of synthetic conjugated estrogens, A (Cenestin) tablets: a slow-release estrogen replacement product.
Stevens RE; Roy R; Phelps KV
J Clin Pharmacol; 2002 Mar; 42(3):332-41. PubMed ID: 11865971
[TBL] [Abstract][Full Text] [Related]
6. Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis.
Dorr MB; Nelson AL; Mayer PR; Ranganath RP; Norris PM; Helzner EC; Preston RA
Fertil Steril; 2010 Nov; 94(6):2365-8. PubMed ID: 20466363
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of a modified-release estrogen tablet.
Bhamra R; Kaercher U; Oleary CM
J Reprod Med; 2010; 55(9-10):404-10. PubMed ID: 21043366
[TBL] [Abstract][Full Text] [Related]
8. Comparison of pharmacokinetics of a conjugated equine estrogen preparation (premarin) and a synthetic mixture of estrogens (C.E.S.) in postmenopausal women.
Bhavnani BR; Nisker JA; Martin J; Aletebi F; Watson L; Milne JK
J Soc Gynecol Investig; 2000; 7(3):175-83. PubMed ID: 10865186
[TBL] [Abstract][Full Text] [Related]
9. Steady-state pharmacokinetics of conjugated equine estrogens in healthy, postmenopausal women.
Mayer P; Tse S; Sendi M; Bourg D; Morrison D
J Reprod Med; 2008 Feb; 53(2):97-101. PubMed ID: 18357800
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics and efficacy of different estrogens are not equivalent.
Ansbacher R
Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism.
Bhavnani BR
Proc Soc Exp Biol Med; 1998 Jan; 217(1):6-16. PubMed ID: 9421201
[TBL] [Abstract][Full Text] [Related]
12. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's.
Bhavnani BR
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):473-82. PubMed ID: 12943738
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
